Clearance Summary
STATUSFIRST CHF (CONGESTIVE HEART FAILURE) NT-PROBNP, MODEL 20204 received FDA 510(k) clearance under submission number K051596, sponsored by Nanogen, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Clinical Chemistry review panel. The statutory decision date of record is 2006-03-13.
- Submission: K051596
- Applicant / Sponsor: Nanogen, Inc.
- Clearance pathway: Traditional
- Review panel: Clinical Chemistry
- Device class: Class II
- Regulation citation: 21 CFR 862.1117
- Decision date: 2006-03-13
Classification & Regulation
This clearance is catalogued under FDA product code NBC and 21 CFR 862.1117, within the Clinical Chemistry review panel as a Class II device.